Casdin Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-800,000
| Closed | -$25.6M | – | 46 |
|
|
2022
Q2 | $25.6M | Sell |
800,000
-525,000
| -40% | -$16.8M | 2.16% | 15 |
|
|
2022
Q1 | $45.9M | Hold |
1,325,000
| – | – | 2.06% | 19 |
|
|
2021
Q4 | $38.8M | Sell |
1,325,000
-600,000
| -31% | -$17.6M | 1.09% | 28 |
|
|
2021
Q3 | $49M | Buy |
1,925,000
+615,000
| +47% | +$15.7M | 1.22% | 28 |
|
|
2021
Q2 | $45.9M | Buy |
1,310,000
+410,000
| +46% | +$14.4M | 1.16% | 24 |
|
|
2021
Q1 | $36.7M | Buy |
900,000
+90,000
| +11% | +$3.67M | 1.09% | 25 |
|
|
2020
Q4 | $35.1M | Buy |
810,000
+415,000
| +105% | +$18M | 1.04% | 26 |
|
|
2020
Q3 | $21.8M | Buy |
395,000
+95,000
| +32% | +$5.24M | 0.98% | 25 |
|
|
2020
Q2 | $18.9M | Hold |
300,000
| – | – | 1.12% | 27 |
|
|
2020
Q1 | $15.3M | Hold |
300,000
| – | – | 1.63% | 19 |
|
|
2019
Q4 | $23.8M | Hold |
300,000
| – | – | 2.19% | 15 |
|
|
2019
Q3 | $14.6M | Hold |
300,000
| – | – | 1.51% | 21 |
|
|
2019
Q2 | $15.8M | Hold |
300,000
| – | – | 1.48% | 22 |
|
|
2019
Q1 | $15.9M | Sell |
300,000
-50,000
| -14% | -$2.65M | 1.74% | 19 |
|
|
2018
Q4 | $14.4M | Sell |
350,000
-90,000
| -20% | -$3.69M | 2.46% | 18 |
|
|
2018
Q3 | $16.7M | Sell |
440,000
-40,000
| -8% | -$1.52M | 2.03% | 19 |
|
|
2018
Q2 | $21.7M | Sell |
480,000
-120,000
| -20% | -$5.42M | 3.03% | 14 |
|
|
2018
Q1 | $29M | Buy |
600,000
+85,000
| +17% | +$4.11M | 5.1% | 8 |
|
|
2017
Q4 | $20.3M | Buy |
515,000
+135,000
| +36% | +$5.31M | 4.94% | 9 |
|
|
2017
Q3 | $11.8M | Buy |
380,000
+165,000
| +77% | +$5.12M | 3.33% | 15 |
|
|
2017
Q2 | $5.88M | Buy |
215,000
+113,500
| +112% | +$3.1M | 2.17% | 19 |
|
|
2017
Q1 | $3.74M | Sell |
101,500
-202,500
| -67% | -$7.46M | 2.21% | 14 |
|
|
2016
Q4 | $4.39M | Buy |
304,000
+64,000
| +27% | +$925K | 3.63% | 11 |
|
|
2016
Q3 | $5.53M | Sell |
240,000
-190,000
| -44% | -$4.38M | 4.48% | 9 |
|
|
2016
Q2 | $7.13M | Buy |
430,000
+325,000
| +310% | +$5.39M | 7.1% | 4 |
|
|
2016
Q1 | $1.67M | Buy |
105,000
+40,000
| +62% | +$634K | 1.91% | 17 |
|
|
2015
Q4 | $2.1M | Buy |
+65,000
| New | +$2.1M | 1.86% | 18 |
|